Biotech Values

[JJM760]

Not sure what percentage of patients might be able to discontinue. Let's see how this plays out. Should a company I have invested help to cure cancer in some form and I am only able to see a 5,000% return instead of a 10,000%, I promise you I won't complain. For the record, if Ariad never went higher than $22 again, I think I should get down on my knees and praise God considering my first buys were at $1.26.

As far as the 20 bil MC, I am still waiting for your response to my message (http://investorshub.advfn.com/boards/read_msg.aspx?message_id=80866234) of Ariad's many other shots on goal. Specifically, in your questioning of Ariad's valuation, to my knowledge you have never really entertained to prospects for 113. Any opinion of what has been presented on 113 to date?